InsiderTrades

Form 4 for ELAN Elanco Animal Health Inc

Accepted 2026-05-19 16:38:26 ET · period of report 2026-05-15 · accession 0001479079-26-000025 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2026-05-19 16:38 2026-05-15 ELAN Simmons Jeffrey N Pres, CEO AND Dir, Dir P - Purchase $20.09 +4,971 172.0K +3% +$99.8K
D 2026-05-19 16:38 2026-05-15 ELAN Simmons Jeffrey N Pres, CEO AND Dir, Dir A - Grant $19.86 +142.34 24.3K +0.6% +$2,827

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-05-15 P A 4,971 $20.09 171,971 I By Revocable Trust — —
2 Derivative Deferred Stock Units 2026-05-15 A A 142.34 $19.86 24,306.46 D — · — to — 142.34 Common Stock (F1) Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. (F2) Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. (F2) Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.